Location History:
- Sunnyvale, CA (US) (2009 - 2015)
- Gaithersburg, MD (US) (2019 - 2022)
Company Filing History:
Years Active: 2009-2022
Title: Innovations in Oncology: The Contributions of Inventor Xing Cheng
Introduction
Xing Cheng, an innovative inventor based in Sunnyvale, CA, has made significant contributions to the field of oncology through his research and patent filings. With a portfolio of six patents, Cheng has focused on developing advanced therapeutic methods that utilize viral vectors to combat tumors effectively. His work represents a transformative approach to cancer treatment, addressing critical challenges in the application of oncolytic therapies.
Latest Patents
Among Xing Cheng's most notable inventions is a patent for compositions featuring an attenuated Newcastle disease virus (NDV) and methods of use for treating neoplasia. This cutting-edge invention employs a modified mesogenic strain of NDV with a modified F protein cleavage site, rendering it non-pathogenic to poultry while maintaining oncolytic properties. The methodologies associated with this patent offer safe, effective, and reliable means to induce tumor regression in human subjects, overcoming limitations seen with pathogenic strains previously used in therapies.
Career Highlights
Cheng currently works at MedImmune Limited, a leader in the biotechnology industry. His innovative spirit and dedication to research have positioned him as a contributor in the fight against cancer. The development of his latest patent marks a significant milestone in bridging research and practical application in medicine.
Collaborations
Throughout his career, Xing Cheng has collaborated with esteemed colleagues, including Hong Jin and Hyun Jung Park. These partnerships have facilitated the exchange of ideas and expertise, helping to advance his research projects and solidify his contributions in the field of oncology. Such collaborations enhance the overall impact of his work on industry standards and therapeutic practices.
Conclusion
In summary, Xing Cheng is a notable inventor whose work continues to push the boundaries of cancer treatment and research. With six patents to his name, his inventions leveraging non-pathogenic viral vectors signify a promising future in oncology. As researchers like Cheng innovate, they pave the way for safer and more effective therapies that improve patient outcomes globally.